Gene therapy for cancer endorsed by FDA advisory panel. 

The FDA doesn’t need to listen to this panel, but they usually do. Scientists remove T-cells, genetically modify them to attack cancer, then put them back in the bodies of leukemia patients. This would be the first time the FDA approved anything considered to be a “gene therapy product”. learn more